Interestingly, catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by RyR2 mutation, and patients suffering from this condition are also prone to impaired glucose homeostasis and insulin secretion [63]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.